Prognosis

Moderna Set to Start Final-Stage Vaccine Trial in 30,000 People

High-risk patients in trial that’s expected to start July 27
Company is using genetic material to produce virus antibodies

Moderna CEO Is 'Cautiously Optimistic' About Covid-19 Vaccine by Next Year

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Robert Langreth

July 14, 2020 at 4:18 PM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Moderna Inc. posted details of its final-stage vaccine trial on an official government website, confirming that the widely-anticipated trial was still on track to begin this month.